In this study, we investigated how AHA1 affects cell migration, invasion, and the epithelial mesenchymal transition (EMT) signaling pathway in CRC cells, as well as whether AHA1 expression correlates with clinical pathological characteristics such as TNM stages and MIS, to investigate its potential as a prognostic marker of CRC. This evidence concerns the gene AHSA1 and colorectal carcinoma.